References
- Galanello R, Eleftheriou A, Traeger-Synodinos J, et al. Prevention of thalassemias and other haemoglobin disorders. Nicosia, Cyprus: Thalassemia International Federation Publications, 2003
- Rudra T, Chakrabarti S, Sengupta B. α Thalassaemia: Experience of referral cases in Kolkata, India. Int J Hum Genet. 2008;8(4):357–360
- Abolghasemi H, Amid A, Zeinali S, et al. Thalassemia in Iran: Epidemiology, prevention, and management. J Pediatr Hematol Oncol. 2007;29(4):233–328
- Davis JR, Dozy AM, Lubin BH, et al. α-Thalassemia in Blacks is due to gene deletion. Am J Hum Genet. 1979;31(5):569–573
- Sarookhani MR, Asiabanha M. Spectrum of α-thalassemia mutations in Qazvin Province, Iran. Afr J Biotechnol. 2011;10(77):17690–17694
- Bowden DK, Vickers MA, Higgs DR. A PCR-based strategy to detect the common severe determinants of α-thalassaemia. Br J Haematol. 1992;81(1):104–108
- Weatherall DJ, Clegg JB, Eds. The Thalassaemia Syndromes, 4th ed. Oxford, UK: Oxford University Press. 2001:240–245
- Ghotbi N, Tsukatani T. Evaluation of the national health policy of thalassemia screening in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(3):308–318
- Bernini LF. Geographic distribution of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin Genetics, Pathophysiology, and Clinical Management. New York, NY: Cambridge University Press. 2001:878–894
- Tan ASC, Quah TC, Low PS, Chong SS. A rapid and reliable 7-deletion multiplex polymerase chain reaction assay for α-thalassemia. Blood. 2001;98(1):250–251
- Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA. 1977;74(12):5463–5467
- Sanger F, Coulson AR. A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase. J Mol Biol. 1975;94(3):441–448
- Harteveld CL, Yavarian M, Zorai A, et al. Molecular spectrum of α-thalassemia in the Iranian population of Hormozgan: Three novel point mutation defects. Am J Hematol. 2003;74(2):99–103
- Tamaddoni A, Hadavi V, Nejad NH, et al. α-Thalassemia mutation analyses in Mazandaran Province, North Iran. Hemoglobin. 2009;33(2):115–123
- Hadavi V, Taromchi AH, Malekpour M, et al. Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993
- Faramarzi H, Rastegar M, Moghadami M, Taheri M. α-Thalassemia mutations in two provinces of southern Iran: Fars & Kohkeloye and Bouyer Ahmad. Hemoglobin. 2012;36(2):139–143
- Zandian Kh, Nateghi J, Keikhaie B, et al. α-Thalassemia mutations in Khuzestan Province, Southwest Iran. Hemoglobin. 2008;32(6):546–552
- Aba Ghoush MW. Subtype of α thalassemia diagnosed at a medical center in Jordan. Prev Med Bull. 2008;7(5):373–376
- Clark GM, Higgins TN. Laboratory investigation of hemoglobinopathies and thalassemias. Review and update. Clin Chem. 2000;46(8):1284–1290
- Mehrabi M, Alibakhshi R, Fathollahi S, Farshchi MR. The spectrum of β-thalassemia mutations in Kermanshah Province in West Iran and its association with hematological parameters. Hemoglobin. 2013;37(6):544–552